A comparison of the receptor-mediated interaction of malondialdehyde-low density lipoprotein and maleyl-albumin has been examined in human monocytes during differentiation in vitro. The recognition of both ligands by the scavenger receptor of these cells has been confirmed. We now report that human monocytes express a second cellular surface receptor for maleylalbumin that is distinct from the scavenger receptor. The activity of the maleyl-albumin receptor, determined by both binding and lysosomal hydrolytic assays, substantially exceeds that of the scavenger receptor in freshly isolated monocytes. A dramatic and rapid decline in the activity of the maleyl-albumin receptor occurs within 72 to 96 h during differentiation in vitro. At day 7, while only 5-10% of the original activity of the maleyl-albumin receptor remains, it is similar to that of the maximally expressed scavenger receptor. Both the binding and hydrolysis of ligand mediated by the maleyl-albumin receptor are specifically inhibited by a-casein and alkaline-treated albumin; neither of these proteins is recognized by the scavenger receptor.
Introduction
Macrophages play a pivotal role in the process of disposal of foreign pathogens and toxins, in the immune response to foreign antigens, and in the repair of injury. More recently it has become apparent that certain of these functions of macrophages may likewise account for their participation in the development of the atherosclerotic lesions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Studies conducted in 1979 by Gerrity et al. (3) and continued by Gerrity (4, 5) as well as investigations in 1984 by Faggiotto et al. (8) in animals with dietinduced atherosclerosis have convincingly demonstrated that the early events of atherogenesis include the recruitment of blood monocytes to lesion-prone areas in the arterial wall, the migration of monocytes to subendothelial locations within the intima, and the conversion of monocytes to lipid-laden macrophages characteristic of the foam cells of the atherosclerotic lesion.
The potential mechanisms accounting for the massive deposition of cholesteryl esters in macrophages have been actively studied by a number of investigators and have been considered to be initiated by the receptor-mediated uptake of several different classes oflipoproteins and lipoprotein complexes (reviewed in reference 1 1). The scavenger receptor, first described in murine peritoneal macrophages by Goldstein et al. (12) , has been of interest in this regard for several reasons: the internalization and hydrolysis of lipoprotein mediated by the scavenger receptor produce rapid intracellular accumulation of cholesteryl esters derived from hydrolysis and reesterification of lipoprotein-derived cholesterol; the receptor is selectively present on macrophages and endothelial cells from a number of species; and alteration of low density lipoproteins (LDL), either by chemical or cellular modification, is a prerequisite to inducing recognition by the scavenger receptor (1 1) . The scavenger receptor, as isolated from murine P388D1 macrophages, has recently been identified as a glycoprotein of 260,000 D by Via et al. (13) . In addition to facilitating the internalization of modified LDL, receptor engagement by maleyl-albumin or fucoidin, previously identified as competitive ligands for the scavenger receptor (12, 14) , triggers the release of neutral proteases, plasminogen activator, and cytolytic factors from peritoneal macrophages obtained from bacillus Calmett-Guerin-primed mice (15) .
The structures of the binding determinants promoting the recognition of ligands by the scavenger receptor have yet to be elucidated. We have provided evidence that alteration in the conformation of the protein components accounts for the recognition of malondialdehyde-LDL, acetyl-LDL, and succinyl-LDL (16, 17) , as well as ofmaleyl-albumin (18) by the scavenger receptor. During the course of these investigations, we noted that, although maleyl-albumin competed on an equimolar basis with malondialdehyde-LDL for recognition by the scavenger receptor (18) , the rate of hydrolysis of maleyl-albumin by human monocyte macrophages exceeded that of malondialdehyde-LDL.
A direct comparison ofthe interaction of these ligands with human monocytes maintained in culture was then initiated to determine ifmaleyl-albumin, like malondialdehyde-LDL (12, 19) , was indeed a ligand selectively recognized by the scavenger receptor. The studies reported here present evidence that, in addition to the scavenger receptor, there is a second, distinct receptor that participates in the binding, internalization, and lysosomal hydrolysis of maleyl-albumin in the human cells. (19, 20) .
Subjects. Normal subjects were recruited from the staff and student body at the University ofCalifornia, Los Angeles. No one received drugs that might have affected serum cholesterol levels or lipid metabolism. All had normal hematocrits, leukocyte and differential counts, serum cholesterol, and triglycerides. Informed consent was obtained in writing from each person.
Separation of cells. 500 ml of blood was taken after an overnight fast, and the monocytes were separated from 300 ml of venous blood by counterflow centrifugation (method BB in Fogelman et al. [19] ).
Cell culture. Cells were suspended in 30% autologous serum in Dulbecco's modified Eagle's medium supplemented with 24 mM NaHCO3, 10 mM 442-hydroxyethyl) I-piperazineethanesulfonic acid, 8 ,g insulin/ ml, and 0.25 ig of fungizone/ml (called medium B to be consistent with our previous publications [19, 20] ). Samples (0.5 ml) ofthe cell suspension containing 1.0 X 106 cells for studies to be conducted within 18 h after isolation of the monocytes, or 0.5-ml samples of the cell suspension containing 0.5 X 106 cells for studies to be conducted with monocytes maintained >24 h in culture were transferred to 2.0-cm2 polystyrene wells (Falcon 3047) and incubated at 370C in a humidified, 5% CO2 incubator. The medium was aspirated and replaced with fresh medium of the same composition twice weekly.
Classification and viability ofthe cells. The cells were classified and their viability was determined as described (21) . Because of the media changes and the washes before beginning each experiment, the cells were 99% monocyte macrophages before the radioactive lipoproteins were added. More than 95% ofthe cells were viable at the end ofthe incubation.
Preparation ofsera. Autologous serum was prepared from 200 ml of blood as described in Fogelman et al. (19) .
Preparation and chemical modification of proteins. Human LDL (d 1.0 19-1.063 g/ml) was isolated from the serum of individual healthy human subjects by ultracentrifugation (22) . :-Very low density lipoproteins isolated from plasma ofcholesterol-fed rabbits were kindly provided by Dr. Van Lenten of this laboratory. LDL and human albumin were modified by malondialdehyde as described (16) and dialyzed against 0.01 M sodium phosphate, pH 7.4, and 0.15 M sodium chloride, 0.01% EDTA (buffer A).
The half-cystyl derivative of crystallized bovine plasma albumin (3 g) was prepared by the method of King and Spencer (23) (29) . The extent of lysine modification was determined by the method of Habeeb (30) with trinitrobenzenesulfonic acid as the difference in lysyl residues of modified and unmodified protein preparations. Molar ratios were calculated assuming a total molecular weight of 500,000 for protein of LDL (31), 66,210 for half-cystyl bovine plasma albumin (32) , 68,900 for maleyl-albumin (15) , and 27,400 for bovine a-casein (33) . Chemical derivatization of LDL by malondialdehyde typically resulted in modification of 38-48% of the lysyl residues of the apolipoprotein B polypeptides; maleylation, acetylation, and reductive methylation of albumin resulted in modification of >94% ofthe peptidyl lysines. The concentrations of protein samples used in cellular assay, given in molar terms, were calculated from the molecular weights stated above and the protein concentrations determined by the method of Lowry et al. (34) with bovine plasma albumin as a standard. Cellular assays. Before initiating studies, cells in culture were washed three times with l-ml vol of Dulbecco's modified Eagle's medium containing 10 mM 4-(2-hydroxyethyl) I-piperazineethanesulfonic acid (medium C). Cells to be used in binding studies were chilled for 60 min at 40C before initiating the binding protocol described in the figure legends. After 3 h of gentle rotation on a platform (60 rpm), the cells were sequentially washed four times with 1 ml of phosphate-buffered saline containing 0.2% bovine serum albumin and one time with I ml ofphosphate-buffered saline; the first wash was allowed to sit 10 min before proceeding with the remaining washes in rapid succession. Each well then received 0.4 ml of 0.1 N sodium hydroxide, and after 30 min at 370C the cellular extract was quantitatively transferred to gamma vials for determination of radioactivity. Wells without cells, prepared by incubation with 30% autologous serum in medium B for 24 h at 370C, were treated identically to serve as blanks. For studies at 370C, radioactive proteins were added in medium C supplemented with 25 mM NaHCO3 and 2 mg of glucose/ml (medium D) to the cells, and the cells were returned to the incubator for the indicated times. The proteolytic degradation of '251-labeled protein was measured by assaying the amount of '25l-labeled trichloroacetic acid-soluble (noniodide) material formed by the cells and excreted into the culture medium as described by Goldstein and Brown (35) . Corrections were made for the small amounts (<0.01% of total radioactivity added) of '25l-labeled acid-soluble material that was formed in parallel incubations without cells. To measure the amount of '251-lipoprotein associated with cells, the medium containing the radioactive lipoprotein was removed and replaced with 2 ml ofchilled phosphate-buffered saline containing 0.2% bovine serum albumin. The cells were placed on ice for 10 min, and the washing procedure described for binding studies was employed. Binding analyses of freshly isolated monocytes were conducted at 4°C as described by Van 
Results
In an earlier investigation we determined the activity of the scavenger receptor of human monocytes cultured in vitro by assaying the rate of hydrolysis of '251-malondialdehyde-MDA-LDL (MDA-LDL),' and showed that the activity decreased within several hours after adherence ofthe cells (19) . The activity 1 . Abbreviations used in this paper: malondialdehyde-, succinyl-, acetyl-, maleyl-, or reductively methylated-protein, protein chemically modified by malondialdehyde, succinic anhydride, acetic anhydride, maleic anhydride, or formaldehyde with borohydride reduction, respectively; maleyl-BPA, maleyl-bovine plasma albumin; MDA-LDL, malondialdehyde-LDL.
of the scavenger receptor gradually developed as a function of time in culture and was maximally expressed in macrophages derived from monocytes after a week in culture (19) . Thus, comparison of the interaction of maleyl-albumin and malondialdehyde-LDL with human monocytes was initiated in the more mature cells to ensure that optimal activity ofthe scavenger receptor was present. Fig. 1 shows the rates of degradation of both radioiodinated ligands as a function of molar concentration. Both the saturation kinetics and the total rates of degradation differed markedly for'251I-MDA-LDL (Fig.I A) and'251-maleylalbumin ( Fig.1 B) . Polyinosinic acid has previously been shown to be an effective and specific inhibitor of ligands recognized by the scavenger receptor of murine peritoneal macrophages (14) and human monocyte macrophages (17). The ability of polyinosinic acid to suppress effectively the degradation of'251I-MDA-LDL is also shown in Fig. 1 A. In contrast, as shown in Fig. 1 BA the hydrolysis of'251I-maleyl-albumin was only partially inhibited by the addition of polyinosinic acid. The rates of hydrolysis of'251I-MDA-LDL and 1251-maleyl-albumin that were specifically suppressed by the addition of polyinosinic acid are compared in Fig. 1 C. The kinetics for hydrolysis of the two ligands appeared similar, with saturation for malondialdehyde-LDL occurring at -30 nM (15 ,ug/ml) and for maleyl-albumin at -100 nM (7 ,ug/ml).
We have previously determined that maleyl-albumin competes on an equimolar basis with MDA-LDL for uptake and hydrolysis mediated by the scavenger receptor (18) . The data of Fig.I implied that the converse did not apply. This was supported by cross-competition analyses as shown in Fig. 2 . Nonradioactive malondialdehyde-LDL only partially competed with1251-maleylalbumin, whether tested at a concentration near saturation of the scavenger receptor by malondialdehyde-LDL (Fig. 2 B) or at a concentration near saturation of the scavenger receptor by maleyl-albumin (Fig. 2 A) . Furthermore, the ability of a 40-fold molar excess of malondialdehyde-LDL to suppress the hydrolysis of'251-maleyl-albumin diminished from 45 to 25% as the concentration of'251-maleyl-albumin increased. In the same experiments, nonradioactive maleyl-albumin readily suppressed 80% of the hydrolysis of 1251-maleyl-albumin (Fig. 2, A and B) . In both cases, 50% inhibition of the hydrolysis of '251I-maleyl-albumin was produced at the same molar ratio of nonradioactive to radioactive maleyl-albumin.
Additional competition experiments with several other known inhibitors of the uptake of ligand by the scavenger receptor were conducted. As shown in Fig. 3 , dextran sulfate and fucoidin readily suppressed >85% ofthe hydrolysis of125I-MDA-LDL mediated by the scavenger receptor, as previously demonstrated by Goldstein, Brown, and colleagues (11, 12, 14) . Furthermore, the ability of dextran sulfate to compete could be abolished by the addition of spermine (Fig. 3 A) . Both fucoidin and dextran sulfate were less effective in preventing the hydrolysis of 1251-maleyl-albumin. The effect of dextran sulfate upon the hydrolysis of '251-maleyl-albumin could be prevented by the addition of spermine. Competitive experiments conducted with polyinosinic acid produced results similar to those obtained with fucoidin and dextran sulfate (data not shown).
Taken together, these results confirmed that polyinosinic acid, dextran sulfate, fucoidin, and malondialdehyde-LDL each effectively suppressed the uptake and hydrolysis of modified LDL specifically recognized by the scavenger receptor of macrophages (14) . However, since the hydrolysis of maleyl-albumin was only partially suppressed by these same molecules, these data suggested that not only the scavenger receptor but also a second process facilitated the observed degradation of maleyl-albumin in human monocyte macrophages. To examine this possibility, the rate ofdegradation ofmaleyl-albumin as a function ofprotein concentration was determined in the absence or presence of selected competitive inhibitors (Fig. 4 A) . The rates of degradation of maleyl-BPA calculated from the data shown in A as the difference in the rates of hydrolysis in the absence and presence of polyinosinic acid or MDA-LDL (-), are designated by the cross-hatched area and defined as scavenger recep tor-dependent uptake. The rates of hydrolysis of maleyl-BPA, calculated as the difference in the rates of degradation in the absence and presence of nonradioactive maleyl-bovine plasma albumin (e), are designated by the striped area; the rate of hydrolysis of maleyl-BPA determined in this manner which exceeds the scavenger receptor-dependent degradation is designated as the facilitated uptake of maleyl-BPA.
As expected, the addition of either malondialdehyde-LDL or polyinosinic acid suppressed the degradation of '251I-maleylalbumin to the same degree. Thus the use of either of these macromolecules provided a measure of the hydrolysis of 1251I maleyl-albumin that was due to uptake mediated by the scavenger receptor in human monocyte macrophages. The high affinity degradation of 1251I-maleyl-albumin mediated by internalization via the scavenger receptor is shown by the cross-hatched area in Fig. 4 B. The ability of nonradioactive maleyl-albumin to suppress the hydrolysis of 1251-maleyl-albumin to a greater degree than malondialdehyde-LDL (Fig. 2 ) was also confirmed (Fig. 4 A) . Based upon the inhibition by nonradioactive maleylalbumin, a saturating rate of hydrolysis of '25I-maleyl-albumin could be generated (Fig. 4 B) . This hydrolysis of '251-maleylalbumin could be attributed to two processes (Fig. 4 B) : the uptake of ligand by the scavenger receptor (cross-hatched area) and by a second, lower affinity process (striped area). The concentration of 1251-maleyl-albumin necessary to saturate the scavenger receptor was 100 nM (7 jig/ml), whereas a higher concentration of 1251-maleyl-albumin was required to saturate the second component of facilitated uptake. Subsequent studies with three additional preparations of maleyl-bovine plasma albumin, human LDL preparations, and human monocyte macrophages obtained from different normal human subjects have confirmed the validity of the preceding data. Maleyl-albumin of human, rabbit, and porcine origin were as effective on a molar basis as maleyl-bovine plasma albumin in suppressing the hydrolysis of '25I-maleyl-bovine plasma al-bumin (data not shown). We have previously demonstrated that maleyl-albumin after demaleylation retains the ability to compete with the hydrolysis of '25I-maleyl-albumin (18) . Molecules that proved ineffective in suppressing the hydrolysis of either 12511 maleyl-albumin or 1251-MDA-LDL included lysinoalanine (l0-4-10-8 M), N-formyl-methionyl-leucyl-phenyalanine (l04-l0o-" M), human LDL, rabbit #-migrating very low density lipoprotein, and acetyl-, malondialdehyde-, reductively methylated-, or native human serum albumin (data not shown).
A search for molecules specifically preventing the hydrolysis ofmaleyl-albumin mediated by the lower affinity, facilitated uptake component was then initiated. Bovine a-casein proved to be an effective inhibitor. Casein itself was a poor competitor of the interaction of ligand with the scavenger receptor, based upon its inability to suppress the hydrolysis of 1251I-MDA-LDL (Fig. 5  A) . As shown in Fig. 5 B, the hydrolysis of 1251-maleyl-albumin mediated by both the scavenger receptor and the facilitated uptake process was suppressed 50% by casein. Malondialdehyde-LDL and polyinosinic acid each produced a greater degree of suppression, 60 and 70%, respectively. To examine the ability of casein to prevent the hydrolysis of 1251-maleyl-albumin mediated only by the facilitated uptake process, polyinosinic acid was included to inhibit recognition of maleyl-albumin by the scavenger receptor. Under these conditions, casein competed on an equimolar basis with maleyl-albumin (Fig. 5 C) . Results similar to those with casein have been obtained with alkaline-treated albumin (data not shown).
Such competitive assays proved useful in determining that the recognition of maleyl-albumin and malondialdehyde-LDL by human monocyte macrophages differed. It was clear, however, that more definitive evidence than patterns of partial suppression of the hydrolysis of 1251I-maleyl-albumin would be required in order to elucidate the nature of this difference in recognition.
To address this issue, the specific hydrolytic rates of '25I-maleylalbumin and MDA-LDL were determined in human monocytes as a function of time in culture (Fig. 6) . As we have previously demonstrated ( 19) , the activity of the scavenger receptor, determined by the hydrolytic rate of MDA-LDL, increased with the differentiation ofthe monocytes into macrophages in vitro (Fig.  6, A and C) . The specific hydrolysis of '25I-maleyl-albumin, proached that of '25I-MDA-LDL. This comparison becomes more evident in Fig. 7 , in which the ratio of specific hydrolysis of the two ligands is presented as a function of time in culture. The most striking feature is that the specific degradation of maleyl-albumin exceeded that of MDA-LDL by more than two orders of magnitude in the freshly isolated monocyte. Thus, the facilitated uptake of maleyl-albumin noted in the more mature monocyte-macrophages (Fig. 4) appeared in fact to be a process that was most active in the freshly isolated cell.
Several experiments were conducted to determine if extracellular or intracellular processing accounted for the observed hydrolysis ofmaleyl-albumin. Chloroquine (75 ,gM), an inhibitor of lysosomal function (37) , inhibited the degradation of 1251. maleyl-albumin (0.2 and 2.9 nmol/ml) and produced a linear increase in cellular associated radioactivity as a function oftime (0.5, 1, 1.5, 2, 3, and 4 h) in both day 1 and day 8 cells (data not shown). In separate experiments, freshly isolated monocytes or cells maintained for 7 d in culture were co-incubated with maleyl-albumin (0.2 and 2.9 nmol/ml), fucoidin (100 Ag/ml), polyinosinic acid (100 ug/ml), malondialdehyde-LDL (0.06 nmol/ml), or no other addition in medium D containing 0.1% human serum albumin for 48 h. The supernatants were then examined for evidence of extracellular neutral protease activity by hydrolysis of l251-casein as described by Johnson et al. (15) . No evidence of hydrolysis was detected. Supernatants obtained after preincubation (4 h) with nonradioactive maleyl-albumin (0.2 nmol/ml) in cells maintained 9 d in culture and then coincubated with I251-maleyl-albumin for an additional 2 or 4 h likewise failed to produce hydrolysis of the radioiodinated protein. Taken together, these results provide evidence that the observed degradation of '251-maleyl-albumin is the result of intracellular, lysosomal processing after internalization of '251-maleylalbumin.
The binding of '25I-maleyl-albumin as a function of concentration to freshly isolated monocytes provided evidence of a cellular surface binding site for maleyl-albumin (Fig. 8) LDL (30 nM) or maleyl-albumin (100 nM) in the more mature macrophages (Fig. 1 C) . The results of Fig. 7 (Fig. 9 ). 251I-maleyl-albumin specifically bound to the cells substantially exceeded that of MDA-LDL. Of the total amount of maleyl-albumin bound at initial concentrations of either 0.12 or 1.6 gM '251I-maleyl-albumin, the majority could be attributed to binding occurring independently ofthe scavenger receptor. That nonradioactive malondialdehyde-LDL failed to suppress the binding of '25I-maleyl-albumin (Fig. 9, A (Fig. 9, A and B) , and failed to inhibit the interaction of MDA-LDL with the human monocyte (Fig. 5 A Maleyl-albumin is also recognized by the scavenger receptor of macrophages, as first described by Goldstein Figure 9 . Effect of added competitors upon the binding of maleyl-BPA and MDA-LDL to human monocytes. Normal human monocytes were cultured in 30% autologous serum in 0.5 ml of medium B for 18 h and were prepared for studies at 4VC as described in Methods. Each well was preincubated for 1 h at 4VC with 0.5 ml of medium C containing 0.5% bovine serum albumin. The media were removed and 0.5 ml of medium C containing 0.5% bovine serum albumin together with 0.12 nmol/ml (A) or 1.6 nmol/ml (B) of maleyl-BPA (44, (15) demonstrated that addition of maleylalbumin to bacillus Calmett-Guerin-primed cells produced secretion of neutral proteases, plasminogen activator, and cytolytic factor. These responses required a minimal concentration of 730 nM maleyl-albumin for initiation, and the levels of secretion progressively increased as a function of added maleyl-albumin up to the highest concentfation tested, 2.2 ,uM maleyl-albumin. Induction oftumoricidal activity could also be produced in these cells by fucoidin (15) , a competitive inhibitor of the scavenger receptor (14) . The concentrations of maleyl-albumin necessary to induce these cellular events exceed the dissociation constants calculated to be 26 nM for the binding of acetyl-LDL to the scavenger receptor of murine P388D1 macrophages (13) and to be 270 nM for the binding of maleyl-albumin to activated or primed murine peritoneal macrophages (45) . The species origin of the cells as well as the states of differentiation and activation are sufficiently different between the preceding studies conducted with murine peritoneal macrophages (15, 45) and our current investigations in human monocytes that useful comparisons would require further investigation.
In light of our findings, it is of considerable interest that several investigators have demonstrated that casein-and alkalinetreated albumin induce chemotaxis in monocytes and neutrophils obtained from the human, rabbit, and guinea pig (46, 47).
The ability ofmaleyl-albumin to promote chemotaxis in human monocytes is currently under investigation.
Based on the data presented here, we suggest that while maleyl-albumin provides a useful adjunct to investigation of cellular events mediated by the scavenger receptor, the occurrence of a second binding site promoting the internalization and hydrolysis of maleyl-albumin must be taken into account as a potential contributing and complicating event. Furthermore, the presence ofthis exceptionally active receptor-mediated process on freshly isolated monocytes suggests that it may participate in events necessary to the function of the circulating cell that diminish in importance after differentiation of the monocyte to the macrophage in vitro. Progress in addressing these and other questions will be greatly facilitated by identification of the cellular funcSecond Receptor for Maleyl-Albumin on Human Monocytes 687 tion(s) and/or physiological ligand(s) of the maleyl-albumin receptor.
